SMR-CPP Antimicrobial Peptides for Biofilm Disruption
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antimicrobial peptides face challenges in effectively addressing biofilm-associated infections, particularly those caused by drug-resistant bacteria, due to weak activity, nonspecific cytotoxicity, and inability to control intracellular microbial infections.
Innovation Solution
A novel antimicrobial peptide comprising an HIV-1 secretion modulation region (SMR) peptide fused with a cell-penetrating peptide (CPP) domain is used to inhibit biofilm formation and disrupt existing biofilms, either by impregnating or coating biologically compatible materials or administering therapeutically to treat infections.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antibiotics are used to treat biofilm infections, then treatment is simple and straightforward, but effectiveness is dramatically reduced (up to 1000 times less effective) due to bacterial resistance
Solution Approach 1:
The patent changes the chemical structure parameters of antimicrobial agents by using peptide sequences with specific amino acid compositions (rich in hydrophobic and charged residues) rather than conventional antibiotic structures. This structural parameter change enables the peptides to penetrate biofilm matrices and interact with bacterial membranes in ways that conventional antibiotics cannot, overcoming resistance mechanisms.
Solution Approach 2:
The patent employs composite antimicrobial strategies by combining multiple peptide sequences (e.g., Lys-Cecropin B, LL-37, HNP-1) with different mechanisms of action into single compositions. This composite approach ensures that at least some active components remain effective against resistant bacteria, and the synergistic effects enhance overall treatment reliability against biofilm-associated infections.
2Reliability
If existing antimicrobial peptides are used, then they provide some antimicrobial activity, but they exhibit nonspecific cytotoxicity against mammalian cells
Solution Approach 1:
The patent applies local quality differentiation by designing peptides with specific regional characteristics: hydrophobic regions for membrane insertion, charged regions for electrostatic interaction with bacterial surfaces, and amphipathic structures that enable selective targeting. This localized functional differentiation allows the peptides to concentrate their antimicrobial action at the bacterial interface while minimizing interaction with mammalian cell membranes, thereby reducing nonspecific cytotoxicity.
Solution Approach 2:
The patent creates universally effective antimicrobial peptides that can target multiple bacterial species and mechanisms simultaneously. The designed peptides possess multi-functional capabilities including membrane disruption, biofilm penetration, and inhibition of bacterial growth pathways, while maintaining selectivity through evolutionary conservation of target structures in bacteria versus mammalian cells. This universal antimicrobial activity reduces the need for high concentrations that would cause cytotoxicity.
3Reliability
If antimicrobial peptides are administered to treat infections, then they can address microbial pathogens, but they suffer from susceptibility to proteolysis and weak activity
Solution Approach 1:
The patent segments the antimicrobial function into multiple short peptide sequences (e.g., 11-20 amino acids each) rather than using single long peptides. This segmentation reduces the target size for proteolytic enzymes while maintaining or enhancing antimicrobial activity through cooperative action of multiple peptide segments. The shorter segments are inherently more resistant to complete degradation and can be rapidly synthesized and deployed.
Solution Approach 2:
The patent employs short-lived, rapidly turnover antimicrobial peptides that are continuously synthesized and deployed. Rather than relying on long-lasting stable peptides, the system uses short peptides (susceptible to proteolysis) that are rapidly replaced by new synthetic batches. This disposable approach ensures a constant supply of fresh, fully active peptides while the short half-life prevents accumulation of degraded products and reduces the need for complex stabilization strategies.
Data Source
Figure 1~2
Figure 3A~3B
Figure 4A~4B
AI summary
Compositions and methods for reducing the growth of and/or preventing the formation of a microbial biofilm are disclosed. The composition comprises an antimicrobial SMR peptide comprising an HIV-l SMRwt peptide and a cell penetrating peptide (CPP) domain. In some embodiments, the composition further comprises one or more other antimicrobial peptides (AMPs), antibiotics, matrix-inhibiting compounds, matrix-disaggregating compounds, quorum sensing inhibitors, or a combination thereof. In other embodiments, the compositions are used for impregnating or coating an article and/or material surface with the composition to render it less prone to microbial infections.